Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN EXPRESS COAXP · Entity 2839 | Director | November 19, 2012 | November 22, 2012 |
| Vaxart, Inc.AVIR · Entity 6654 | Director · 10% owner | February 13, 2018 | February 15, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN EXPRESS CO
Report date November 19, 2012 · Filed November 22, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 0 |
Reported balance
After 2012-11-19 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2012-11-19 · Sale · Disposed 35,250 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.17. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 0 |
Reported balance
After 2012-11-19 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2012-11-19 · Sale · Disposed 35,250 · Balance 0 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.135. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 35,250 |
Reported balance
After 2012-11-19 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2012-11-19 · Purchase · Acquired 35,250 · Balance 35,250 F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.23. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. |
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 35,250 |
Reported balance
After 2012-11-19 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2012-11-19 · Purchase · Acquired 35,250 · Balance 35,250 F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.24. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. |
| Common StockSEC Table I · non-derivative | Direct | 85,059 |
Reported balance
Holding disclosure · report date 2012-11-19 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 85,059 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.17. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.135. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.23. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.24. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Vaxart, Inc.
Report date February 13, 2018 · Filed February 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 30,793,670 |
Reported balance
After 2018-02-13 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-02-13 · Grant · Acquired 30,793,670 · Balance 30,793,670 F1: Consists of 30,793,670 aggregate shares of Aviragen Therapeutics, Inc. ("Aviragen") common stock received by Care Capital Investments III, LP ("Investments III") and Care Capital Offshore Investments III, LP ("Offshore III") upon conversion of shares of Vaxart, Inc. ("Vaxart") in connection with the merger of Vaxart into Agora Merger Sub, Inc., a wholly owned subsidiary of Aviragen (the "Merger"). In connection with the closing of the Merger, each share of Vaxart common stock was converted into 0.2211 shares of Aviragen common stock. On the closing date of the Merger, the closing price of Aviragen's common stock was $0.82 per share. Following the Merger, Aviragen effected a reverse stock split at a ratio of one new share for every eleven shares of Aviragen common stock outstanding. The effects of such reverse stock split is not reflected here. F2: Consists of (i) 30,287,856 shares held by Investments III and (ii) 505,814 shares held by Offshore III. Care Capital III LLC is the general partner of Investments III LP and Offshore III (collectively, "Care Capital") and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. The reporting person, Richard Markham, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by Care Capital. The reporting person is a managing member of Care Capital III LLC, and serves as a representative of Care Capital on Aviragen's board of directors. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 30,793,670 aggregate shares of Aviragen Therapeutics, Inc. ("Aviragen") common stock received by Care Capital Investments III, LP ("Investments III") and Care Capital Offshore Investments III, LP ("Offshore III") upon conversion of shares of Vaxart, Inc. ("Vaxart") in connection with the merger of Vaxart into Agora Merger Sub, Inc., a wholly owned subsidiary of Aviragen (the "Merger"). In connection with the closing of the Merger, each share of Vaxart common stock was converted into 0.2211 shares of Aviragen common stock. On the closing date of the Merger, the closing price of Aviragen's common stock was $0.82 per share. Following the Merger, Aviragen effected a reverse stock split at a ratio of one new share for every eleven shares of Aviragen common stock outstanding. The effects of such reverse stock split is not reflected here.
F2: Consists of (i) 30,287,856 shares held by Investments III and (ii) 505,814 shares held by Offshore III. Care Capital III LLC is the general partner of Investments III LP and Offshore III (collectively, "Care Capital") and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. The reporting person, Richard Markham, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by Care Capital. The reporting person is a managing member of Care Capital III LLC, and serves as a representative of Care Capital on Aviragen's board of directors. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2018 Filed Feb 15, 2018 21:25 UTC | Vaxart, Inc. AVIR · Entity 6654 | GrantCommon Stock | 30,793,670 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-008682 · doc1.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 30,793,670 F1 · price: Consists of 30,793,670 aggregate shares of Aviragen Therapeutics, Inc. ("Aviragen") common stock received by Care Capital Investments III, LP ("Investments III") and Care Capital Offshore Investments III, LP ("Offshore III") upon conversion of shares of Vaxart, Inc. ("Vaxart") in connection with the merger of Vaxart into Agora Merger Sub, Inc., a wholly owned subsidiary of Aviragen (the "Merger"). In connection with the closing of the Merger, each share of Vaxart common stock was converted into 0.2211 shares of Aviragen common stock. On the closing date of the Merger, the closing price of Aviragen's common stock was $0.82 per share. Following the Merger, Aviragen effected a reverse stock split at a ratio of one new share for every eleven shares of Aviragen common stock outstanding. The effects of such reverse stock split is not reflected here. F2 · ownership.nature: Consists of (i) 30,287,856 shares held by Investments III and (ii) 505,814 shares held by Offshore III. Care Capital III LLC is the general partner of Investments III LP and Offshore III (collectively, "Care Capital") and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. The reporting person, Richard Markham, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by Care Capital. The reporting person is a managing member of Care Capital III LLC, and serves as a representative of Care Capital on Aviragen's board of directors. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| November 19, 2012 Filed Nov 22, 2012 01:29 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Stock | 35,250 | $55.17 | $1,944,636.75 |
DisclosureSEC source: 0001127602-12-031910 · form4.xml · nonDerivative · entry 4 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 35,250 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.24. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| November 19, 2012 Filed Nov 22, 2012 01:29 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Stock | 35,250 | $55.16 | $1,944,531.00 |
DisclosureSEC source: 0001127602-12-031910 · form4.xml · nonDerivative · entry 3 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 35,250 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $55.10 to $55.23. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| November 19, 2012 Filed Nov 22, 2012 01:29 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | SaleCommon Stock | 35,250 | $55.08 | $1,941,464.25 |
DisclosureSEC source: 0001127602-12-031910 · form4.xml · nonDerivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.135. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| November 19, 2012 Filed Nov 22, 2012 01:29 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | SaleCommon Stock | 35,250 | $55.10 | $1,942,310.25 |
DisclosureSEC source: 0001127602-12-031910 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.17. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 10, 2012 Filed May 11, 2012 17:33 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 2,593.8991 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-016559 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,666.411 Underlying: Common Stock · 2,593.8991 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · shares: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 20:08 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $37.71 | $0.00 |
DisclosureSEC source: 0001127602-12-009249 · form4.xml · derivative · entry 3 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,427 shares Expires 2012-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became exercisable in three equal annual installments beginning on the date shown as "Date Exercisable." Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 20:08 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | SaleCommon Stock | 3,427 | $53.43 | $183,104.61 |
DisclosureSEC source: 0001127602-12-009249 · form4.xml · nonDerivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,559 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 20:08 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionCommon Stock | 3,427 | $37.71 | $129,245.88 |
DisclosureSEC source: 0001127602-12-009249 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2011 Filed May 4, 2011 21:34 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,024.498 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-015136 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,578.989 Underlying: Common Stock · 3,024.498 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · kind: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $35.57 | $0.00 |
DisclosureSEC source: 0001127602-11-002570 · form4.xml · derivative · entry 4 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,427 shares Expires 2011-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became exercisable in three equal annual installments beginning on the date shown as "Date Exercisable." Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | SaleCommon Stock | 609 | $44.84 | $27,308.78 |
DisclosureSEC source: 0001127602-11-002570 · form4.xml · nonDerivative · entry 3 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,559 Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | SaleCommon Stock | 2,818 | $44.84 | $126,359.12 |
DisclosureSEC source: 0001127602-11-002570 · form4.xml · nonDerivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,168 Read SEC document |
| January 26, 2011 Filed Jan 27, 2011 22:46 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionCommon Stock | 3,427 | $35.57 | $121,881.26 |
DisclosureSEC source: 0001127602-11-002570 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2010 Filed Apr 27, 2010 23:55 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,164.557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-10-012195 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,169.487 Underlying: Common Stock · 3,164.557 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · shares: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F2 · price: The reported Share Equivalent Units were awarded pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 22, 2010 Filed Apr 26, 2010 16:54 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $42.77 | $0.00 |
DisclosureSEC source: 0001127602-10-011979 · form4.xml · derivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,427 shares Expires 2010-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2010 Filed Apr 26, 2010 16:54 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionCommon Stock | 3,427 | $42.77 | $146,555.66 |
DisclosureSEC source: 0001127602-10-011979 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2009 Filed Apr 29, 2009 19:54 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-009953 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,580.49 Underlying: Common Stock · 3,400 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · shares: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 28, 2008 Filed Apr 30, 2008 20:35 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-002708 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,746.23 Underlying: Common Stock · 3,400 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · shares: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 18:21 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $29.91 | $0.00 |
DisclosureSEC source: 0001127602-08-002659 · form4.xml · derivative · entry 3 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,427 shares Expires 2008-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options vested in three equal annual installments beginning on the date shown as "Date Exercisable." Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 18:21 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Tax withholdingCommon Stock | 2,185 | $46.89 | $102,454.65 |
DisclosureSEC source: 0001127602-08-002659 · form4.xml · nonDerivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,132 F1 · kind: The reported disposition represents the surrender of shares to satisfy the cost of exercise. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 18:21 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionCommon Stock | 3,427 | $29.91 | $102,494.72 |
DisclosureSEC source: 0001127602-08-002659 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 8, 2007 20:48 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Stock | 32,000 | $62.33 | $1,994,560.00 |
DisclosureSEC source: 0001127602-07-003260 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,890 Read SEC document |
| April 23, 2007 Filed Apr 25, 2007 20:03 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-07-001570 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,201.27 Underlying: Common Stock · 3,400 shares Expires not disclosed F1 · derivative.exercise_price: The Share Equivalent Units convert into common stock on a one-for-one basis. F2 · shares: The reported Share Equivalent Units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately and have no expiration date. F4 · balance_after: Includes share equivalent units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| March 19, 2007 Filed Mar 21, 2007 17:45 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 3,427 | $0.00 Strike: $18.33 | $0.00 |
DisclosureSEC source: 0001127602-07-001150 · form4.xml · derivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,427 shares Expires 2007-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in three equal annual installments beginning on April 28, 1998. Read SEC document |
| March 19, 2007 Filed Mar 21, 2007 17:45 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | Exercise / conversionCommon Stock | 3,427 | $18.33 | $62,810.06 |
DisclosureSEC source: 0001127602-07-001150 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 14:57 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Stock | 16,200 | $58.49 | $947,538.00 |
DisclosureSEC source: 0001127602-07-000306 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,422 Read SEC document |
| April 28, 2006 Filed May 1, 2006 21:42 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Stock | 15,000 | $53.93 | $808,950.00 |
DisclosureSEC source: 0001127602-06-001045 · form4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,222 Read SEC document |
| April 24, 2006 Filed Apr 25, 2006 20:43 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 3,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-06-000995 · form4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,709.2 Underlying: Common Stock · 3,400 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalent units convert into common stock on a one-for-one basis. F3 · shares: The reported share equivalent units were acquired pursuant to the Company's 2003 Share Equivalent Unit Plan for Directors and will be settled in cash following termination of service as a Director. F2 · derivative.exercise_date: The share equivalent units are convertible immediately and have no expiration date. F2 · derivative.expiration_date: The share equivalent units are convertible immediately and have no expiration date. F4 · balance_after: Includes share equivalent units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| April 27, 2005 Filed Apr 29, 2005 19:05 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 2,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-05-000125 · doc4.xml · derivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Shares · 2,225 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalent units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The share equivalent units are convertible immediately and have no expiration date. F2 · derivative.expiration_date: The share equivalent units are convertible immediately and have no expiration date. F3 · ownership.direct: Includes share equivalent units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. F4 · ownership.direct: The reported share equivalent units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in ca sh following termination of service as a Director. Read SEC document |
| November 09, 2004 Filed Nov 10, 2004 15:04 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | PurchaseCommon Shares | 10,000 | $54.90 | $549,000.00 |
DisclosureSEC source: 0000004962-04-000211 · doc4.xml · nonDerivative · entry 1 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,222 Read SEC document |
| April 26, 2004 Filed Apr 28, 2004 17:02 UTC | AMERICAN EXPRESS CO AXP · Entity 2839 | GrantShare Equivalent Units · Derivative | 2,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-04-000118 · doc4.xml · derivative · entry 2 LESCHLY JAN · CIK 0001204568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,231.733 Underlying: Common Shares · 2,225 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalent units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The share equivalent units are convertible immediately and have no expiration date. F2 · derivative.expiration_date: The share equivalent units are convertible immediately and have no expiration date. F3 · ownership.direct: Includes share equivalent units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. F4 · ownership.direct: The reported share equivalent units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in ca sh following termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.